Not only chips. Nvidia entering the Medical and Fitness Industry

Nvidia, a chipmaker from California, had a successful year with focus on AI tech.

By the end of February, Nvidia had exceeded expectations and achieved a market capitalization of more than $2 trillion. This makes the company one of the three largest companies in terms of market capitalization, just behind Microsoft and Apple.

Company's latest boom seems to be explained by a fairly simple formula.

Advances in artificial intelligence industries beyond technology such as health care and finance racing to figure out how to implement AI here. To do this, you need chips known as graphics processors, or GPUs to power the artificial intelligence. What is obvious is that Nvidia has the right chips.

Nvidia's areas of interest range from software to pharmaceuticals and healthcare. Moon Surgical raised $55.4 million in May, according to Cathay Health, a healthcare investment firm that participated in financing round. Support co-created by Sofinnova Partners and Nventures, on of Nvidia's investment arms.

Nvidia also disclosed in a February SEC filing that is had interests in small AI companies such as Recursion Pharmaceuticals, a drug discovery company, and Soundhound AI, which develops speech recognition technology.

The investments seem to have paid off. The daily cites Nvidia's financial reports, which show its investments were worth about $1.55 billion in January compared to $300 million from the previous year. Since January 2023, Nvidia shares are up 239%.

Jensen Huang emphasized the ecosystem's promising growth potential.

— Biological companies, or those in health care, or those providing financial services, and creators of artificial intelligence and large language models, or others that deal with autonomous vehicles or robotics... All these startups and large companies in the healthcare, financial services , automotive and the like run on the NVIDIA platform, Huang commented in February. — We support them directly.